We've Been Busy -AIT Bioscience

We’ve Been Busy

Top News Stories

Continued Growth to Assist Your Needs
Gary Gabriel and Blythe Logan Recently we have welcomed Gary Gabriel, Ph.D. and Blythe Logan to AIT Bioscience. Both of these individuals will be assisting our commercial and customer-facing activities.
Ready to head to the 13th Annual Boulder Peptide Symposium?
The Evolution of Therapeutic Peptide Structures as it Relates to Analytical Challenges This year, Senior Scientist Jim Eckstein, will be attending the 13th Annual Boulder Peptide Symposium in Boulder, Colorado from September 24-27th. Every year, AIT Bioscience attends the Boulder Peptide Symposium because it continues to offer great value to us and our sponsors through opportunities to share our research, meet up with other industry leaders, and stay current with the latest advances. Here is a closer look at a few of the reasons we keep coming back to the Boulder Peptide Symposium.
AIT Bioscience Announces New High-Resolution Mass Spectrometry Service Line
High-resolution mass spectrometry (HRMS) At AIT Bioscience, we recently expanded our service offerings to include high-resolution mass spectrometry (HRMS).The Thermo Q-Exactive Plus® platform allows us to offer new capabilities in mass spectrometry including assays for conjugated peptides, fusion proteins, antibodies, and antibody drug conjugates (ADC’s). These HRMS offerings for large molecule analysis complement our current small molecule and ligand binding expertise.
AIT Bioscience Attends 2018 Midwest Society of Quality Assurance (MWSQA) Meeting 
Midwest Society of Quality Assurance (MWSQA) Meeting From July 24th -25th, Senior Director of Assurance, Robyn Durr-Henry, represented AIT Bioscience at the 2018 MWSQA meeting in Cleveland, Ohio. With multiple breakout sessions to participate in throughout the event, attendees were able to select sessions that pertained to their areas of interest. The theme of this year’s meeting was “Navigating the Seas of Quality.”
AIT Bioscience CEO Terri Pascarelli Recognized as a 2018 PharmaVOICE 100 Honoree
Terri Pascarelli As an organization that values our people, we at AIT Bioscience are excited to announce that our CEO, Terri Pascarelli, has been acknowledged as an honoree for the 2018 PharmaVOICE 100. This recognition comes shortly after the Healthcare Businesswomen’s Association’s (HBA) recognized Pascarelli as the organization’s Strategic Transformation Achievement Recognition (STAR) award recipient at the 29thWoman of the Year event in May.
AIT Bioscience Attends Land O’ Lakes Bioanalytical Conference
From July 9th to 12th, AIT Bioscience’s Chief Scientific Officer, Shelby Anderson, Ph.D., attended the 2018 Land O’ Lakes Bioanalytical Conference in Madison, Wisconsin. The three-day conference encourages an open exchange of scientific and methodological applications for bioanalysis.
AIT Bioscience Introduces Expedited Discover PK Services
Because PK assays are one of the most common and essential tests performed in drug development, sponsors often desire expedited delivery to meet development needs and project deadlines. To strengthen the value that we provide to our sponsors throughout the drug development process, we are now offering our sponsors an expedited approach to PK assays.
AIT Bioscience Adds Value to Sponsors with Innovative ELN System
At AIT Bioscience, we have taken an innovative approach to utilizing the electronic laboratory notebook (ELN). Since 2011, an Oracle-based solution, IDBS E-workbook ELN has been the backbone of our operations.
AIT Bioscience Grows Laboratory Expertise
AIT Bioscience continues to develop our team, adding breadth and depth to our areas of expertise. We are excited to introduce six new employees, who have already contributed value to the company.
AIT Bioscience Acquires New Instrumentation 
AIT Bioscience recently invested in a new Q Exactive™ Hybrid Quadrupole-Orbitrap™ Mass Spectrometer. This new instrument will allow AIT Bioscience to enhance its discovery protein mass spec capabilities and create additional capacity for protein and peptide work.
Journal of Chromatography B Features AIT Bioscience’s Research
AIT Bioscience and Teva Pharmaceuticals share their sensitive bioanalytical method for the measurement of lidocaine and a key metabolite from transdermal application in the Journal of Chromatography B. Those that contributed to this bioanalytical method include Qian LiTobias MagersBrad King, Brian J. Engel, Ray BakhtiarCharisse Green and Ronald Shoup.
AIT Bioscience Positions for Growth
Mark Cameron joins AIT Bioscience as the Vice President, Scientific Services, Ligand Binding Assays (LBA). Mark brings more than 25 years of immunoassay development and validation experience to AIT Bioscience.  Mark will lead the company’s LBA programs, continuing to grow the service line in the protein bioanalysis space.
 AIT Bioscience Expands its Team
AIT Bioscience continues to grow its team to add breadth and depth to our areas of expertise and to also expand our presence in specific geographic areas. We are excited to introduce two new members of our business development team and one new member to our commercial operations team.
 AIT Bioscience Presents at the 12th Annual Workshop on Recent Issues in Bioanalysis
From April 9 – April 13, 2018, Philadelphia, PA was the host city for the 12th Annual Workshop on Recent Issues in Bioanalysis (WRIB). AIT Bioscience was fortunate to have representation from three of our colleagues, Jennifer Vance, Ashley Brant and Cameron Brown. These three attended the main workshop focused on LC-MS/MS, hybrid LBA-LC/MS/MS, and LBA approaches to bioanalysis as well as full-day short courses on Biomarkers and Internal Standard Response Challenges.
 AIT Bioscience Presents Poster at the Society of Quality Assurance Annual Meeting
During this year’s meeting, AIT Bioscience’s Quality Assurance Specialist, Jasmine Roach, had the opportunity to present her poster, The Case of the Failing Pipette – A Case Study of Auditing in an Electronic Bioanalytical Laboratory. 
AIT Bioscience Joins Sponsors and Partners at the SOT 57th Annual Meeting and ToxExpo
San Antonio, Texas hosted this year’s Society of Toxicology’s (SOT) 57th Annual Meeting and ToxExpo. AIT Bioscience’s Dave Dehler had the opportunity to attend this event and was able to connect and learn about the latest research in the toxicology field.
AIT Bioscience Attends CED Life Science Conference
February 27th and 28th was buzzing with Life Sciences energy in Raleigh, North Carolina. The annual Council for Entrepreneurial Development (CED) Life Science Conference was taking place and AIT Bioscience’s Dave Dehler had the opportunity to be a part of it.
AIT Bioscience Presents at Delaware Valley Drug Metabolism Discussion
On Wednesday, January 17th, AIT Bioscience’s Technical Business Manager, Jennifer Vance was an invited speaker at the Delaware Valley Drug Metabolism Discussion Group in Langhorne, PA.
AIT Bioscience Welcomes New Scientist, Jim Eckstein
AIT Bioscience welcomes Jim Eckstein to our scientific ranks. Jim brings more than 20 years of experience in LC/MS analysis, including the analysis of small molecule pharmaceuticals, biomarkers, as well as peptide and protein biotherapeutics.
Healthcare Businesswomen’s Association Names AIT Bioscience CEO Terri Pascarelli as STAR Recipient
AIT Bioscience is pleased to announce that the company’s CEO, Terri Pascarelli, has been recognized with the Strategic Transformation Achievement Recognition (STAR) award by Healthcare Businesswomen’s Association (HBA). Pascarelli was announced as one of the company’s 2018 award recipients during a reception at the JP Morgan healthcare conference this week in San Francisco.
AIT Bioscience Expands, Welcomes Three New Employees
AIT Bioscience continues to expand its team to add breadth and depth to our areas of expertise. We are excited to introduce three new employees, who have already been great assets to AIT Bioscience: Maral Llewellyn, Aimee Rinas and Nick Williams
AIT Bioscience Employees Present at i3 North American Community Forum
In early October, two AIT Bioscience employees, April Pisek and Jessica White, presented at the i3 North American Community Forum in Seattle, Washington at the request of IDBS. The presentations focused on electronic storage of training documentation utilizing the IDBS E-workbook software.
AIT Bioscience Presents at 14th annual Indiana Life Sciences Summit
On October 9th and 10th, AIT Bioscience employees had the opportunity to attend and present at the 14th Annual Indiana Life Sciences Summit in downtown Indianapolis. This summit is presented by BioCrossroads and highlights and celebrates innovations in life sciences from Indiana and around the world through both business and scientific tracks.
AIT Bioscience Recognized with Awards at Recent WRIB
AIT Bioscience showcased its scientific prowess by garnering the Top LC-MS/MS Small Molecule Poster Award for our case study on chiral assay development and validation via diastereomer derivatization.
AIT Bioscience Offers New Screening Level Assay
A fit-for-purpose approach to bioanalytical assay support balances intended use of data with regulatory requirements and budgets.
AIT Bioscience Featured in Contract Pharma
In Contract Pharma’s October issue, AIT Bioscience’s article “Robust Assay Designs” highlights where some unexpected challenges and expenses can arise and how these can be overcome.
First FDA Audit at AIT Bioscience Using Fully Electronic Records
The FDA conducted a directed and general surveillance audit at AIT Bioscience, LLC on August 3-7, 2015.
AIT Bioscience Ranks No. 179 on Inc. Magazine’s 2015 List of America’s Fastest-Growing Private Companies
AIT Bioscience, LLC, ranked No. 179 on Inc. magazine’s 34th annual Inc. 500, an exclusive ranking of the nation’s fastest-growing private companies.
AIT Bioscience Names Terri Pascarelli as New CEO
AIT Bioscience, LLC has appointed Terri Pascarelli, BS, MBA, as Chief Executive Officer and member, Board of Directors.
AIT Bioscience selected as one of 2013 ‘Indiana Companies to Watch’
Thirty-three companies, including AIT Bioscience, from 14 Indiana counties have earned a place in Indiana’s sixth annual field of ‘Companies to Watch.’
Bioanalysis-Zone interviews Ronald Bowsher
  In March 2013, Ronald Bowsher (AIT BioScience) talks to Alexandra Sklan (bioanalysis-zone.com) at Bioanalysis about his current bioanalytical career, his involvement in the American Association of Pharmaceutical…
AIT BioScience proudly supports the Indianapolis Chamber Orchestra
  At AIT Bioscience, we are committed to helping local companies and causes bring their missions to life in effort to enhance the lives of fellow Hoosiers. We are very proud to support the mission and talent of the Indianapolis Chamber Orchestra (ICO). The ICO advances and promotes music composed for the small orchestra through professional concert performances and educational programs.
AIT Bioscience Taps Ligand Binding Assay Expert Dr. Ron Bowsher as Senior Research Advisor
  AIT Bioscience is pleased to announce that Dr. Ron Bowsher, an industry expert in bioanalysis of ligand binding assays, has partnered with the company as a senior research advisor bringing with him an impressive background in biotherapeutic drug research in both traditional pharmaceutical and the CRO industries.
AIT Bioscience Names Emilio Córdova Senior Vice President of Business Development
  Discover more about Emilio Cordova, the newest addition to the AIT Bioscience executive leadership team.
AIT Bioscience Announces Collaboration with Perfinity Biosciences For Automated Protein Analysis
Learn more about the collaborative relationship between AIT Bioscience and Perfinity Biosciences.
AIT Bioscience Partners with PreClinOmics
Read about AIT Bioscience’s new working partnership with PreClinOmics.
Take a Look at Our New Laboratory
Find out what AIT Bioscience’s new 18,000 sq. ft. laboratory has to offer.
Archives:    2011 Archive | 2010 Archive | 2009 Archive |